Search for cancer therapies could be transformed by innovative technique
the ONA take:
Researchers based at the University of Illinois have now developed a technique to pinpoint novel, medically relevant products produced created by bacteria. Many companies have steered away from natural product discovery due to the difficulties developing new products, but using their new technique, the investigators quickly has success developing a novel product derived from soil bacteria. Soil bacteria has been historically a good source, as it produces antibiotics to repel competitors.
The investigators used genomics to screen the soil bacteria in their search for novel antibiotic products. As the screening takes place, compounds of interest are tagged for review. The tags add mass, allowing the researchers to detect the compounds via mass spectrometry. (The most popular method typically used to identify novel products is bioassay-guided isolation, which has the tendency to produce similar results on repeated trials by "rediscovering" the most active or abundant compounds to the exclusion of the rarer compounds, which go unnoticed.) The sensitivity of mass spectrometry allows for novel products present at lower abundance.
Research results was reported in the journal ACS Chemical Biology.
Search for new cancer therapies could be transformed by innovative technique
In a study reported in ACS Chemical Biology, University of Illinois researchers developed a new technique to quickly uncover novel, medically relevant products produced by bacteria.
Past techniques involved screening more than 10,000 samples to find a novel product, said principal investigator Doug Mitchell, assistant professor of chemistry and Institute for Genomic Biology (IGB) member.
- Immunotherapy May Benefit Some Patients with Papillary Thyroid Carcinoma
- Screening Recommendations for Children with Common Cancer Predisposition Syndromes
- Significance of Prostate Cancer Treatment-Related Factors Differ in Black, White Men
- New Study Questions Standard Dosage for Treating Metastatic Non-Small Cell Lung Cancer
- Superior Tolerability, Efficacy With Alectinib in Treatment-Naïve ALK-poistive NSCLC
- Survivorship Care Plans: Providing A Blueprint for Health Care After Cancer
- Cancer Recurrence Fear Reduced by Novel Psychological Intervention
- Multifaceted Role of the Nurse Navigator Includes Palliative, Supportive Care
- Patient Navigators Found to Boost Lung Cancer Screening Rates
- Lack of Transfusion Services a Barrier to Hospice Care for Patients With Blood Cancers
- Aspirin Use May Lower Breast Cancer Risk in Women with Diabetes
- Ethnic Differences, Cultural Barriers Negatively Impact Mammography Follow-up Among Asian Ethnic Groups
- Study Questions Safety of E-cigarettes vs Regular Tobacco Cigarettes
- Changes in Pulmonary Function Tests in Breast Carcinoma Patients Treated With Locoregional Post-mastectomy Radiotherapy: Results of a Pilot Study
- Increases in Liver Cancer Incidence Influenced by Higher Rates of Comorbidities
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|